{"id":419,"date":"2025-01-30T11:38:16","date_gmt":"2025-01-30T10:38:16","guid":{"rendered":"https:\/\/cmyc.w.uib.no\/?p=419"},"modified":"2025-01-30T11:38:16","modified_gmt":"2025-01-30T10:38:16","slug":"nyheitsbrev-til-donorar-og-samarbeidspartnarar","status":"publish","type":"post","link":"https:\/\/cmyc.w.uib.no\/nb\/2025\/01\/30\/nyheitsbrev-til-donorar-og-samarbeidspartnarar\/","title":{"rendered":"Newsletter to donors and collaborators"},"content":{"rendered":"<p class=\"cvGsUA direction-ltr align-start para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Kj\u00e6re pasientar, p\u00e5r\u00f8rande,<\/span> <span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">friske frivillige og samarbeidspartnarar. Dette \u00e5ret har vore s\u00e6rs spanande for forskingssgruppa og for forskingsmilj\u00f8et her.<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Hausten 2023 var Professor Bj\u00f8rn Tore Gjertsen saman med professor Simona Chera og professor Eivind Dale Valen vart invitert til \u00e5 s\u00f8kje om eit nytt KG Jebsen medisinsk forskingssenter. Dei kom vidare i prekvalifiseringa og i Februar 2024 vart det annonsert at dei vann fram.<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Etableringa av eit nytt forskingssenter vil fokusere p\u00e5 \u00e5 forbetre diagnostisering og evaluering av<\/span> <span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">behandlinga. Dette vil senteret jobbe mot gjennom \u00e5 studere cellenes reaksjon kort tid etter behandlingsstart. S\u00e5leis kan forskarane finne ut kva pasientar som responderer p\u00e5 behandlinga og kven som ville hatt betre nytte av anna behandling. Danninga av senteret bringer saman tre etablerte forskarar som saman vil utvikle metodar for \u00e5 utvikle diagnostiske metodar. Senteret skal ogs\u00e5 auke tilbudet av behandlingsstudier til pasienter og styrke<\/span> <span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">norsk og nordisk samarbeid kring blodkreftforsking.<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Nyheitssakane som prega \u00e5ret 2024 var i stor grad kring planane og etableringa av dette forskingssenteret p\u00e5 myeloid kreft. Senteret skal samarbeide tett med<\/span> <span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Blodkreft foreninga. Sj\u00f8lve opninga av senteret skjedde saman med blodkreftforeninga g i same lokala som deira m\u00f8te.<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">I forbindelse med det nye forskingssenteret vart det danna ei ny nettside om senteret. Her kan dykk f\u00f8lgje artiklar, nyheiter og informasjon fr\u00e5 oss i forskingsmilj\u00f8et. Sida er under arbeid.<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Bileter og nyheitssak fr\u00e5 opninga kan dykk lese om her:<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">https:\/\/cmyc.w.uib.no\/2024\/09\/27\/the-first-annual-symposium-and-opening-c-myc\/<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Under Helse Vest si \u00e5rlege forskingskonferanse vart det annonsert at Bj\u00f8rn Tore Gjertsen vann forskingspris for sitt initiativ til \u00e5 betre diagnostikk behandlinga for AML pasientar. Forskingsprisen vert \u00e5rleg delt ut til ein kandidat tilsett hj\u00e5 ein av Helse Vest sine f\u00f8retak.<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Forskingsmilj\u00f8et og Bj\u00f8rn Tore har hatt god grunn til \u00e5 feire i \u00e5r. Berre ei veke etter forskingsprisen delte kreftforeninga nyheita om tildeling p\u00e5 8 millionar kroner. Desse midlene skal brukast til \u00e5 analysere blodpr\u00f8var til AML pasientar for \u00e5 unders\u00f8kje respons p\u00e5 behandlinga. Midlane lar forskingsgruppa fortsette arbeidet med \u00e5 forbetre diagnostiske metodar for \u00e5 tilpasse behandlinga etter respons for kvar pasient.<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Nyheitsbrevet i PDF form kan du finne gjennom denne lenkja: <a href=\"https:\/\/www.canva.com\/design\/DAGP-tcTI9Q\/e3NdmF84F2c9urSTM_ri2A\/view?utm_content=DAGP-tcTI9Q&amp;utm_campaign=designshare&amp;utm_medium=link2&amp;utm_source=uniquelinks&amp;utlId=hb45455c52b\">https:\/\/www.canva.com\/design\/DAGP-tcTI9Q\/e3NdmF84F2c9urSTM_ri2A\/view?utm_content=DAGP-tcTI9Q&amp;utm_campaign=designshare&amp;utm_medium=link2&amp;utm_source=uniquelinks&amp;utlId=hb45455c52b<\/a><\/span><\/p>\n<p>Registrerte donorar skal ogs\u00e5 ha motteke nyheitsbrevet per e-post.<\/p>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Beste Helsing<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-start para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Tara Hel\u00e9n Dowling, PhD kandidat<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Kj\u00e6re pasientar, p\u00e5r\u00f8rande, friske frivillige og samarbeidspartnarar. Dette \u00e5ret har vore s\u00e6rs spanande for forskingssgruppa og for forskingsmilj\u00f8et her. Hausten 2023 var Professor Bj\u00f8rn Tore Gjertsen saman med professor Simona <a class=\"read-more\" href=\"https:\/\/cmyc.w.uib.no\/nb\/2025\/01\/30\/nyheitsbrev-til-donorar-og-samarbeidspartnarar\/\">LES MER<\/a><\/p>","protected":false},"author":5388,"featured_media":213,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"_EventAllDay":false,"_EventTimezone":"","_EventStartDate":"","_EventEndDate":"","_EventStartDateUTC":"","_EventEndDateUTC":"","_EventShowMap":false,"_EventShowMapLink":false,"_EventURL":"","_EventCost":"","_EventCostDescription":"","_EventCurrencySymbol":"","_EventCurrencyCode":"","_EventCurrencyPosition":"","_EventDateTimeSeparator":"","_EventTimeRangeSeparator":"","_EventOrganizerID":[],"_EventVenueID":[],"_OrganizerEmail":"","_OrganizerPhone":"","_OrganizerWebsite":"","_VenueAddress":"","_VenueCity":"","_VenueCountry":"","_VenueProvince":"","_VenueState":"","_VenueZip":"","_VenuePhone":"","_VenueURL":"","_VenueStateProvince":"","_VenueLat":"","_VenueLng":"","_VenueShowMap":false,"_VenueShowMapLink":false,"footnotes":""},"categories":[10,12],"tags":[],"class_list":["post-419","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-patient-and-public"],"_links":{"self":[{"href":"https:\/\/cmyc.w.uib.no\/nb\/wp-json\/wp\/v2\/posts\/419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cmyc.w.uib.no\/nb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cmyc.w.uib.no\/nb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cmyc.w.uib.no\/nb\/wp-json\/wp\/v2\/users\/5388"}],"replies":[{"embeddable":true,"href":"https:\/\/cmyc.w.uib.no\/nb\/wp-json\/wp\/v2\/comments?post=419"}],"version-history":[{"count":1,"href":"https:\/\/cmyc.w.uib.no\/nb\/wp-json\/wp\/v2\/posts\/419\/revisions"}],"predecessor-version":[{"id":421,"href":"https:\/\/cmyc.w.uib.no\/nb\/wp-json\/wp\/v2\/posts\/419\/revisions\/421"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cmyc.w.uib.no\/nb\/wp-json\/wp\/v2\/media\/213"}],"wp:attachment":[{"href":"https:\/\/cmyc.w.uib.no\/nb\/wp-json\/wp\/v2\/media?parent=419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cmyc.w.uib.no\/nb\/wp-json\/wp\/v2\/categories?post=419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cmyc.w.uib.no\/nb\/wp-json\/wp\/v2\/tags?post=419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}